Phase 3 study to treat lumbar degenerative disc disease (DDD). The study is looking to evaluate the efficacy of donor stem cells plus hyaluronic acid (HA) injected into painful lumbar discs.
The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.
Principal Investigator- Gary Ghiselli, MD
Sub-Investigators- J. Scott Bainbridge, MD (injectionist), Drew Trainor, DO, Susan Estes, NP-C, and Michelle Hogue, FNP-BC
